Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension [Phase 2]
Phase 2 clinical trial update for s086 tablets in mild to moderate essential hypertension.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination [Phase 3]
Phase 3 trial update for BR1010 in essential hypertension patients not adequately responding to fimasartan/amlodipine.
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension [Phase 2]
Phase 2 trial update determined the optimal dose of AD-209 in patients with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension [Phase 2]
Phase 2 trial evaluating efficacy and safety of LCI699 in essential hypertension has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension [Phase 3]
A long-term safety study evaluating the combination of aliskiren, amlodipine, and hydrochlorothiazide in participants with essential hyperte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension [Phase 3]
A Phase III study evaluating AGSAVI for essential hypertension is in progress, with status not publicly listed.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: FimasaRtan-basEd BP Targets After Drug SwitcHing
A completed clinical trial evaluating a fimasartan-based blood pressure target after drug switching for essential hypertension; results post…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of co-administered ezetimibe/rosuvastatin with telmisartan in patients with esse…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Safety Study of RMJH-111b to Treat Essential Hypertension [Phase 1, Phase 2]
Clinical trial update for RMJH-111b in essential hypertension completed Phase 1 and Phase 2 with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension [Phase 2]
Phase 2 dose-finding study of ACT-132577 (Aprocitentan) in essential hypertension completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Fimasartan in the Senior Subjects [Phase 3]
Phase 3 trial update for fimasartan in elderly subjects (≥70) with essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Effect of Atorvastatin on Carotid Intima Media Thickness [Phase 4]
Phase 4 trial update on atorvastatin and its effect on carotid intima-media thickness in patients with essential hypertension and hyperchole…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension [Phase 3]
Phase 3 trial update evaluating whether perindopril reduces recurrence of atrial fibrillation in patients with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of a combination treatment of fimasartan and atorvastatin in essential hypertension with dy…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension [Phase 3]
Phase 3 long-term study of CS-3150 as monotherapy or in combination for essential hypertension in Japanese patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects [Phase 2]
Phase 2 study evaluating efficacy and safety of CS-3150 in Japanese subjects with essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Clinical Trial on Remote Ischemic Conditioning and Hypertension（HOPE） [Phase 2]
Phase 2 clinical trial update on remote ischemic conditioning for essential hypertension.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial update of a fixed-dose combination (fimasartan/amlodipine/rosuvastatin) in patients with essential hypertension and dyslipidem…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of arotinolol hydrochloride on morning blood pressure and heart rate in ess…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia [Phase 4]
Phase 4 trial update on azilsartan medoxomil for essential hypertension and type 2 diabetes mellitus completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: RAS Peptide Profiles in Patients With Arterial Hypertension
This clinical trial update reports on a completed study examining renin-angiotensin system peptide profiles in patients with essential hyper…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension
This completed observational study evaluated the efficacy and safety of Nebivolol in Korean patients with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension [Phase 3]
Phase 3 trial comparing azilsartan medoxomil to valsartan in Chinese participants with essential hypertension has been completed.
-
CLINICAL_TRIALS safety_alert · 2019-02-01Clinical Trial Update: Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)
Post-authorization long-term safety surveillance study of Kanarb® (fimasartan) in essential hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy [Phase 3]
Phase 3 trial evaluating efficacy and safety of a fixed-dose combination of olmesartan medoxomil, amlodipine, and hydrochlorothiazide in pat…